🇺🇸 FDA
Patent

US 11660327

Methods and compositions for oral administration of proteins

granted A61KA61K35/60A61K38/2278

Quick answer

US patent 11660327 (Methods and compositions for oral administration of proteins) held by Oramed Ltd. expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Oramed Ltd.
Grant date
Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K35/60, A61K38/2278, A61K38/28, A61K38/56